Syra Health Corp. (SYRA): Valuation
TTM figures as of June 30, 2026
Syra Health Corp. trades at 99.5 times trailing earnings. The Healthcare median P/E is 22.9.
Earnings yield 1.01%. ROIC 10.2%. Piotroski F-score 5 of 9. Net cash $2.1M.
36 month-end valuation observations are on file, starting September 2023.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is SYRA cheap versus its own history?
Syra Health Corp. trades at 99.5 times trailing earnings. The Healthcare median P/E is 22.9.
What is SYRA's free-cash-flow yield?
Free-cash-flow yield is trailing free cash flow divided by the live market cap. It is omitted when free cash flow is missing.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.